The National Institutes of Health (NIH) Sexual & Gender Minority Research Office Request for Letters of Intent and Nominations for SGM Investigator Awards Program, 16681-16682 [2019-08065]
Download as PDF
Federal Register / Vol. 84, No. 77 / Monday, April 22, 2019 / Notices
Name of Committee: Integrative,
Functional and Cognitive Neuroscience
Integrated Review Group, Sensorimotor
Integration Study Section.
Date: June 6, 2019.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Washington Plaza Hotel, 10 Thomas
Circle, NW, Washington, DC 20005.
Contact Person: John Bishop, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5182,
MSC 7844, Bethesda, MD 20892, (301) 408–
9664, bishopj@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: April 16, 2019.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory
Committee Policy.
Name of Committee: National Cancer
Institute Special Emphasis Panel; SEP–4: NCI
Clinical and Translational R21 and Omnibus
R03.
Date: June 13–14, 2019.
Time: 5:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda North Marriott Hotel, 5701
Marinelli Road, North Bethesda, MD 20852.
Contact Person: Eduardo E. Chufan, Ph.D.,
Scientific Review Officer, Research
Technology and Contract Review, Branch
Division of Extramural Activities, National
Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W254, Bethesda, MD 20892–
9750, 240–276–7975 chufanee@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: April 16, 2019.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–07967 Filed 4–19–19; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2019–07964 Filed 4–19–19; 8:45 am]
BILLING CODE 4140–01–P
amozie on DSK9F9SC42PROD with NOTICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meetings
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
National Institutes of Health
Name of Committee: National Cancer
Institute Special Emphasis Panel; Improving
Outcomes for Pediatric Cancer Survivors.
Date: June 7, 2019.
Time: 12:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
7W606, Rockville, MD 20850, (Telephone
Conference Call).
Contact Person: Timothy Meeker, M.D.,
Scientific Review Officer, Resource and
Training Review Branch, Division of
Extramural Activities, National Cancer
Institute, NIH, 9609 Medical Center Drive,
Room 7W606 Bethesda, MD 20892–9750,
240–276–6464 meekert@mail.nih.gov.
VerDate Sep<11>2014
17:22 Apr 19, 2019
Jkt 247001
The National Institutes of Health (NIH)
Sexual & Gender Minority Research
Office Request for Letters of Intent and
Nominations for SGM Investigator
Awards Program
AGENCY:
National Institutes of Health,
HHS.
ACTION:
Notice; call for Letters of Intent.
The National Institutes of
Health (NIH) Sexual & Gender Minority
Research Office (SGMRO) is requesting
letters of intent for the second annual
Investigator Awards Program. The NIH
Sexual and Gender Minority (SGM)
Investigator Awards Program was
developed to recognize early-stage
investigators who have made
substantial, outstanding research
contributions in areas related to SGM
health and who are poised to become
future leaders or are already leading the
field of SGM health research. The NIH
SGMRO is currently soliciting
nominations for the 2019 NIH SGM
Investigator Awards. The NIH SGMRO
will make two non-monetary awards
this year.
DATES: Letters of intent to apply due
May 20, 2019 and final nomination
submissions due June 10, 2019.
SUMMARY:
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
16681
FOR FURTHER INFORMATION CONTACT:
Karen Parker, Ph.D., MSW, Director,
Sexual & Gender Minority Research
Office (SGMRO), 6011 Executive
Boulevard, Suite 206, Rockville, MD
20852, klparker@mail.nih.gov, 301–
451–2055.
SUPPLEMENTARY INFORMATION: ‘‘Sexual
and gender minority’’ is an umbrella
term that encompasses lesbian, gay,
bisexual, and transgender populations
as well as those whose sexual
orientation, gender identity and
expressions, or reproductive
development varies from traditional,
societal, cultural, or physiological
norms.
The Sexual and Gender Minority
Research Office (SGMRO) coordinates
sexual and gender minority (SGM)–
related research and activities by
working directly with the NIH
Institutes, Centers, and Offices. The
Office was officially established in
September 2015 within the NIH
Division of Program Coordination,
Planning, and Strategic Initiatives
(DPCPSI) in the Office of the Director.
The SGMRO has the following
research-related goals: (1) Expand the
knowledge base of SGM health and
well-being through NIH-supported
research; (2) Remove barriers to
planning, conducting, and reporting
NIH-supported research about SGM
health and well-being; (3) Strengthen
the community of researchers and
scholars who conduct research relevant
to SGM health and well-being; and (4)
Evaluate progress on advancing SGM
research.
2019 Award Details
Two non-monetary awards of
recognition will be offered to early stage
investigators who demonstrate both
contemporary achievement in and a
commitment to an area of SGM-related
health research. The awardees will be
invited, with all travel expenses covered
(limited to reimbursement based on
Federal Travel Regulations and HHS
and NIH guidance), to give a lecture at
the NIH in September 2019. This event
will be webcast live and the
presentations will be archived and
available for future viewing.
Eligibility Criteria
The following individuals are not
eligible to be nominated: Federal
employees and interns/fellows; federal
contractors; members of the NIH SGM
Research Working Group, and previous
NIH SGM Investigator awardees.
• At the time of the nomination due
date, June 10, the candidate must meet
the NIH’s definitions of an early stage
investigator (ESI) (https://
E:\FR\FM\22APN1.SGM
22APN1
16682
Federal Register / Vol. 84, No. 77 / Monday, April 22, 2019 / Notices
grants.nih.gov/grants/guide/notice-files/
NOT-OD-17-101.html).
amozie on DSK9F9SC42PROD with NOTICES
Letters of Intent
A Letter of Intent (LOI) to submit a
nomination is required (nominees may
self-nominate and submit their own
LOIs). The LOI should be a 1-page,
single-spaced Word or PDF document
and include:
1. Nominee’s name, title, affiliation,
and date of terminal degree.
2. eRA Commons ID.
a. Before submitting the LOI,
researchers should confirm ESI status is
correctly marked in their eRA Commons
(https://era.nih.gov/) profile. If the
status is incorrect, please contact the
NIH eRA Service Desk (https://
grants.nih.gov/support/) to
resolve the issue before submitting an
LOI.
3. SGM research focus of nominee’s
work.
Attach the LOI (as a Word or PDF
document) to an email and send it to
sgmhealthresearch@od.nih.gov with the
subject line ‘‘2019 SGM Investigator
Award Letter of Intent’’ no later than
11:59 p.m. local time on May 20, 2019.
Nominations
Nomination packages may be
submitted by the nominee or a
nominee’s mentor or colleague.
Nomination packages must be a single
PDF file that includes:
1. CV and NIH Biosketch including a
link (URL) to the nominee’s My
Bibliography in PubMed.
a. If you do not have a My
Bibliography in PubMed, refer to these
simple step-by-step instructions to save
your citations in PubMed to a ‘‘My
Bibliography.’’
b. Use the URL that PubMed
automatically generates when you
change your ‘‘My Bibliography’’ sharing
setting to public.
2. Letter of nomination (1,000 words
or less) from a mentor or colleague
familiar with the nominee’s work,
addressing the nominee’s innovative
contribution to the field of SGM health
research, crosscutting and collaborative
nature of that research, trajectory of
career development, and leadership
strengths. The strongest letters will
demonstrate the lasting significance and
impact of the nominee’s work to date.
3. Two letters of endorsement from
other mentors or colleagues. Letters of
endorsement may be less encompassing
than the letter of nomination, but
should address similar themes.
4. A PDF of a key, peer-reviewed
article published in the past 24-month
period, which is first-authored by the
nominee. If in press, please provide the
VerDate Sep<11>2014
17:22 Apr 19, 2019
Jkt 247001
accepted paper and the letter of
acceptance from the journal.
After compiling all the above
elements into a single PDF file, attach
the PDF to an email, and send it to
sgmhealthresearch@od.nih.gov with the
subject line header ‘‘2019 NIH SGM
Investigator Award Nomination’’ no
later than 11:59 p.m. local time on June
10, 2019.
Review and Selection Process
• Stage 1: The SGMRO will assemble
a review panel composed of NIH staff
with relevant expertise. This panel will
provide recommendations for two
awardees to the SGMRO Director and
the DPCPSI Director.
• Stage 2: The SGMRO and DPCPSI
Directors will review the
recommendations and select the final
two awardees.
Dated: April 16, 2019.
Lawrence A. Tabak,
Deputy Director, National Institutes of Health.
[FR Doc. 2019–08065 Filed 4–19–19; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Library of Medicine; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable materials,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Library of
Medicine Special Emphasis Panel COI/Career
Award.
Date: December 5, 2019.
Time: 11:00 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Library of Medicine/Center
for Scientific Review, 6701 Rockledge Drive,
Bethesda, MD 20892, (Virtual Meeting).
Contact Person: Yanli Wang, Ph.D., Health
Data Scientist, Division of Extramural
Programs, National Library of Medicine, NIH,
6705 Rockledge Drive, Suite 301, Bethesda,
MD 20892–7968, 301–594–4933,
yanli.wang@.nih.gov.
PO 00000
Frm 00046
Fmt 4703
Sfmt 9990
(Catalogue of Federal Domestic Assistance
Program No. 93.879, Medical Library
Assistance, National Institutes of Health,
HHS)
Dated: April 16, 2019.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–07965 Filed 4–19–19; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Center for Complementary &
Integrative Health; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Center for
Complementary and Integrative Health
Special Emphasis Panel; HEAL Initiative:
Pragmatic Randomized Controlled Trial of
Acupuncture for Management of Chronic
Low Back Pain in Older Adults.
Date: May 30, 2019.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Gaithersburg Marriott
Washingtonian Center, 9751 Washingtonian
Blvd., Gaithersburg, MD 20878.
Contact Person: Jessica Marie McKlveen,
Ph.D., Scientific Review Officer, Office of
Scientific Review, Division of Extramural
Activities, NCCIH, NIH, 6707 Democracy
Boulevard, Suite 401, Bethesda, MD 20892,
jessica.mcklveen@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.213, Research and Training
in Complementary and Alternative Medicine,
National Institutes of Health, HHS)
Dated: April 15, 2019.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–07954 Filed 4–19–19; 8:45 am]
BILLING CODE 4140–01–P
E:\FR\FM\22APN1.SGM
22APN1
Agencies
[Federal Register Volume 84, Number 77 (Monday, April 22, 2019)]
[Notices]
[Pages 16681-16682]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-08065]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
The National Institutes of Health (NIH) Sexual & Gender Minority
Research Office Request for Letters of Intent and Nominations for SGM
Investigator Awards Program
AGENCY: National Institutes of Health, HHS.
ACTION: Notice; call for Letters of Intent.
-----------------------------------------------------------------------
SUMMARY: The National Institutes of Health (NIH) Sexual & Gender
Minority Research Office (SGMRO) is requesting letters of intent for
the second annual Investigator Awards Program. The NIH Sexual and
Gender Minority (SGM) Investigator Awards Program was developed to
recognize early-stage investigators who have made substantial,
outstanding research contributions in areas related to SGM health and
who are poised to become future leaders or are already leading the
field of SGM health research. The NIH SGMRO is currently soliciting
nominations for the 2019 NIH SGM Investigator Awards. The NIH SGMRO
will make two non-monetary awards this year.
DATES: Letters of intent to apply due May 20, 2019 and final nomination
submissions due June 10, 2019.
FOR FURTHER INFORMATION CONTACT: Karen Parker, Ph.D., MSW, Director,
Sexual & Gender Minority Research Office (SGMRO), 6011 Executive
Boulevard, Suite 206, Rockville, MD 20852, [email protected], 301-
451-2055.
SUPPLEMENTARY INFORMATION: ``Sexual and gender minority'' is an
umbrella term that encompasses lesbian, gay, bisexual, and transgender
populations as well as those whose sexual orientation, gender identity
and expressions, or reproductive development varies from traditional,
societal, cultural, or physiological norms.
The Sexual and Gender Minority Research Office (SGMRO) coordinates
sexual and gender minority (SGM)-related research and activities by
working directly with the NIH Institutes, Centers, and Offices. The
Office was officially established in September 2015 within the NIH
Division of Program Coordination, Planning, and Strategic Initiatives
(DPCPSI) in the Office of the Director.
The SGMRO has the following research-related goals: (1) Expand the
knowledge base of SGM health and well-being through NIH-supported
research; (2) Remove barriers to planning, conducting, and reporting
NIH-supported research about SGM health and well-being; (3) Strengthen
the community of researchers and scholars who conduct research relevant
to SGM health and well-being; and (4) Evaluate progress on advancing
SGM research.
2019 Award Details
Two non-monetary awards of recognition will be offered to early
stage investigators who demonstrate both contemporary achievement in
and a commitment to an area of SGM-related health research. The
awardees will be invited, with all travel expenses covered (limited to
reimbursement based on Federal Travel Regulations and HHS and NIH
guidance), to give a lecture at the NIH in September 2019. This event
will be webcast live and the presentations will be archived and
available for future viewing.
Eligibility Criteria
The following individuals are not eligible to be nominated: Federal
employees and interns/fellows; federal contractors; members of the NIH
SGM Research Working Group, and previous NIH SGM Investigator awardees.
At the time of the nomination due date, June 10, the
candidate must meet the NIH's definitions of an early stage
investigator (ESI) (https://
[[Page 16682]]
grants.nih.gov/grants/guide/notice-files/NOT-OD-17-101.html).
Letters of Intent
A Letter of Intent (LOI) to submit a nomination is required
(nominees may self-nominate and submit their own LOIs). The LOI should
be a 1-page, single-spaced Word or PDF document and include:
1. Nominee's name, title, affiliation, and date of terminal degree.
2. eRA Commons ID.
a. Before submitting the LOI, researchers should confirm ESI status
is correctly marked in their eRA Commons (https://era.nih.gov/)
profile. If the status is incorrect, please contact the NIH eRA Service
Desk (https://grants.nih.gov/support/) to resolve the issue
before submitting an LOI.
3. SGM research focus of nominee's work.
Attach the LOI (as a Word or PDF document) to an email and send it
to [email protected] with the subject line ``2019 SGM
Investigator Award Letter of Intent'' no later than 11:59 p.m. local
time on May 20, 2019.
Nominations
Nomination packages may be submitted by the nominee or a nominee's
mentor or colleague. Nomination packages must be a single PDF file that
includes:
1. CV and NIH Biosketch including a link (URL) to the nominee's My
Bibliography in PubMed.
a. If you do not have a My Bibliography in PubMed, refer to these
simple step-by-step instructions to save your citations in PubMed to a
``My Bibliography.''
b. Use the URL that PubMed automatically generates when you change
your ``My Bibliography'' sharing setting to public.
2. Letter of nomination (1,000 words or less) from a mentor or
colleague familiar with the nominee's work, addressing the nominee's
innovative contribution to the field of SGM health research,
crosscutting and collaborative nature of that research, trajectory of
career development, and leadership strengths. The strongest letters
will demonstrate the lasting significance and impact of the nominee's
work to date.
3. Two letters of endorsement from other mentors or colleagues.
Letters of endorsement may be less encompassing than the letter of
nomination, but should address similar themes.
4. A PDF of a key, peer-reviewed article published in the past 24-
month period, which is first-authored by the nominee. If in press,
please provide the accepted paper and the letter of acceptance from the
journal.
After compiling all the above elements into a single PDF file,
attach the PDF to an email, and send it to [email protected]
with the subject line header ``2019 NIH SGM Investigator Award
Nomination'' no later than 11:59 p.m. local time on June 10, 2019.
Review and Selection Process
Stage 1: The SGMRO will assemble a review panel composed
of NIH staff with relevant expertise. This panel will provide
recommendations for two awardees to the SGMRO Director and the DPCPSI
Director.
Stage 2: The SGMRO and DPCPSI Directors will review the
recommendations and select the final two awardees.
Dated: April 16, 2019.
Lawrence A. Tabak,
Deputy Director, National Institutes of Health.
[FR Doc. 2019-08065 Filed 4-19-19; 8:45 am]
BILLING CODE 4140-01-P